The National Institute for Health and Care Excellence (NICE) has issued final guidance recommending Chiesi’s idebenone within ...

China-based Everest Medicines (HKEX: 1952) has secured full regulatory approval for Nefecon (budesonide) in Taiwan, marking the last of its Asian territories to grant the go-ahead for the ...